Welcome to CDC stacks | An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus - 49916 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus
  • Published Date:
    Dec 16 2012
  • Source:
    Curr Fungal Infect Rep. 6(4):288-295.
Filetype[PDF-324.12 KB]


Details:
  • Keywords:
  • Pubmed ID:
    29118894
  • Pubmed Central ID:
    PMC5672947
  • Description:
    Aspergillosis has emerged as an important contributor to infection-related morbidity and mortality in susceptible populations. This comes at a time when we are also seeing an increase in the vulnerable populations themselves. At the same time, some parts of the world are reporting an increased incidence of aspergillosis refractory to triazole therapy. Resistance to triazole drugs may have major implications for aspergillosis management since our antifungal armamentarium is limited. This review gives an overview of populations at risk of developing aspergillosis and highlights resistance mechanisms that may contribute to morbidity and mortality in these vulnerable populations.

  • Document Type:
  • Collection(s):
  • Main Document Checksum:
No Related Documents.
You May Also Like: